- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01227005
Early Whole Blood in Patients Requiring Transfusion After Major Trauma
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Background: The acquired coagulopathy of trauma is responsible for a large percentage of early deaths in civilian trauma practice and is a major cause of battlefield mortality. Widespread recognition has provided a rationale for fundamental changes in the initial management of severely injured patients through prevention of hypothermia, damage control surgery, massive transfusion protocols and early triage to intensive care units for optimized resuscitation. Despite these major advances, hemorrhage remains a leading cause of early death in both civilian trauma and military combat casualty care. However, it is unclear how early whole blood will affect coagulopathy in this cohort of patients as compared to the current standard of care. Objective/Hypothesis: The proposal will assess if patients who require massive transfusion can be accurately predicted early after emergency department arrival and assess if the use of stored whole blood during initial resuscitation will reduce transfusion needs compared to transfusion with component therapy and thus improve outcome.
Study Design: As a first step in testing this hypothesis, we will test commonly utilized point of care analysis devices and determine their reliability in predicting transfusion requirements in severely injured trauma patients within 20 minutes after arrival in the emergency department. Furthermore, we will prospectively randomize severely injured patients who require a blood transfusion to receive either stored whole blood and pooled platelets or component therapy (packed red blood cells, fresh frozen plasma, and platelets, our current standard of care) and compare the ability of stored whole blood to reduce transfusion needs and improve clinical outcomes.
Relevance: Severe uncontrollable coagulopathy in major trauma patients continues to be a major determinant of trauma mortalities. The proposed effort aims to provide an early, coagulopathy-based prediction model to identify patients at risk for massive transfusion. Moreover, our proposal intends to evaluate early stored whole blood transfusion in this at risk patient population and determine stored whole blood's ability to prevent or control severe coagulopathy compared to standard transfusion care.
Studietype
Inschrijving (Werkelijk)
Fase
- Fase 4
Contacten en locaties
Studie Locaties
-
-
Texas
-
Houston, Texas, Verenigde Staten, 77030
- Memorial Hermann Hospital - Texas Medical Center
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- 18 years of age or older.
Meet Code 3 status; Code 3 is determined by the following criteria (Patients must meet at least one of the following physiologic and/or anatomic criteria):
- Physiologic criteria indicating high risk or life threatening injuries
- GCS <10 (Glasgow Coma Scale)
- SBP <90 (Systolic blood pressure)
- RR <10 or >29 (Respiratory rate)
- HR >120 (Heart rate)
- intubated
- Base Deficit > 6
- Anatomic criteria indicating high risk or life threatening injuries
- Any penetrating injury to torso, groin, or neck
- Amputation proximal to the ankle or wrist
- Uncontrolled external hemorrhage
- Two or more long bone fractures
- Pelvic fracture
- Paraplegia or quadriplegia
- Combination trauma with burns ≥ 20% BSA (body surface area)
- Demonstrate evidence of blood loss due to injury, requiring transfusion in the ED.
Exclusion Criteria:
- Death thought to be imminent, suggesting a futile resuscitation effort
- Known or assumed religious objection to blood products
- Do not resuscitate order in place
- Women who present to the ED who are obviously pregnant.
- Patients who appear to the ED wearing the -opt-out‖ bracelet provided at the community consultation.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Actieve vergelijker: Whole Blood
Whole Blood plus pooled platelets
|
The intervention will be either a) administration of 1 unit of whole blood plus pooled products or b) administration of component therapy (red blood cells, plasma, platelets).
|
Actieve vergelijker: Component Therapy
Red blood cells, plasma, platelets
|
The intervention will be either a) administration of 1 unit of whole blood plus pooled products or b) administration of component therapy (red blood cells, plasma, platelets).
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Units of Blood Products Required During the First 24 Hours After Emergency Department Admission
Tijdsspanne: first 24 hours after ED admission
|
Compare the ability of whole blood to reduce initial 24-hour transfusion requirements as compared to component therapy (red blood cells, plasma, and platelet units)
|
first 24 hours after ED admission
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
24-hour Mortality
Tijdsspanne: First 24 hours after ED admission
|
Mortality rate at 24 hours after arrival
|
First 24 hours after ED admission
|
30-day Mortality
Tijdsspanne: first 30 days after ED admission
|
Evaluate 30-day mortality among those receiving whole blood compared to those receiving component therapy
|
first 30 days after ED admission
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Bryan Cotton, MD, The University of Texas Health Science Center, Houston
Publicaties en nuttige links
Algemene publicaties
- Erber WN, Tan J, Grey D, Lown JA. Use of unrefrigerated fresh whole blood in massive transfusion. Med J Aust. 1996 Jul 1;165(1):11-3. doi: 10.5694/j.1326-5377.1996.tb124809.x.
- Mohr R, Martinowitz U, Lavee J, Amroch D, Ramot B, Goor DA. The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations. J Thorac Cardiovasc Surg. 1988 Oct;96(4):530-4.
- Oberman HA. The indications for transfusion of freshly drawn blood. JAMA. 1967 Jan 9;199(2):93-7. No abstract available.
- Grosso SM, Keenan JO. Whole blood transfusion for exsanguinating coagulopathy in a US field surgical hospital in postwar Kosovo. J Trauma. 2000 Jul;49(1):145-8. doi: 10.1097/00005373-200007000-00022.
- Ledgerwood AM, Lucas CE. A review of studies on the effects of hemorrhagic shock and resuscitation on the coagulation profile. J Trauma. 2003 May;54(5 Suppl):S68-74. doi: 10.1097/01.TA.0000064513.59253.70.
- Cotton BA, Podbielski J, Camp E, Welch T, del Junco D, Bai Y, Hobbs R, Scroggins J, Hartwell B, Kozar RA, Wade CE, Holcomb JB; Early Whole Blood Investigators. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Ann Surg. 2013 Oct;258(4):527-32; discussion 532-3. doi: 10.1097/SLA.0b013e3182a4ffa0. Erratum In: Ann Surg. 2014 Jul;260(1):178.
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- W81XWH-07-1-0229
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Probleem met trauma/letsel
-
Hospital Universitari Son DuretaEspen; This research prize was funded by Nestle Nutrition Institute and by Fresenius...VoltooidMatig tot ernstig trauma, zoals gedefinieerd door een | Injury Severity Score (ISS) > 12 punten werden opgenomen in het onderzoek.Spanje
-
University Hospital, BordeauxVoltooidChirurgie | Oogzenuw en Pathway InjuryFrankrijk
-
CAMC Health SystemOnbekendAKI (Acute Kidney Injury) als gevolg van traumaVerenigde Staten
-
Ain Shams UniversityVoltooidAKI (Acute Kidney Injury) als gevolg van traumaEgypte
-
Mayo ClinicVoltooidOverbelastingsletsel | Repetitive Strain InjuryVerenigde Staten
-
Nantes University HospitalVoltooidEvaluatie van postoperatieve ongemakken bij kinderen na extractie van tijdelijke tanden (DEXTRAFANT)Pijn na extractie (PEP) | Post-extractie Lip or Cheek Biting Injury (PEBI) | Bloeding na extractie (PEB) | Tand verwijderenFrankrijk
-
University Hospital, AngersWerving
-
Arrowhead Regional Medical CenterVoltooidTrauma letsel | Trauma bot | Vasculair traumaVerenigde Staten
-
National Center for Complementary and Integrative...VoltooidPijn | Carpaal tunnel syndroom | Cumulatieve traumastoornissen | Repetitive Strain InjuryVerenigde Staten
-
Chang, Steve S., M.D.Santa Barbara Cottage Hospital; Accumetrics, Inc.VoltooidHoofdletsel Trauma BluntVerenigde Staten
Klinische onderzoeken op Transfusion of blood products
-
Methodist Health SystemWerving
-
Children's Hospital SrebrnjakBelupo; Podravka d.d.Werving
-
Children's Hospital SrebrnjakBelupo; Podravka d.d.WervingLichaamsgewicht | Overgewicht en obesitasKroatië
-
SVR GroupNog niet aan het werven
-
Universidad Católica San Antonio de MurciaVoltooidGlycemische index | Cognitieve prestatiesSpanje
-
Universidad Católica San Antonio de MurciaVoltooid
-
Derming SRLVoltooid
-
Universidad Católica San Antonio de MurciaWerving
-
Abbott NutritionNog niet aan het werven
-
Altria Client Services LLCVoltooidTabak gebruikVerenigde Staten